Saturday, April 12, 2025

Technology | 2019.12.04

Hackensack Meridian Health Invests in Adaptive Phage Therapeutics, Aiming to Kill 'Superbugs' as Part of Bear's Den Innovation Program

EDISON, N.J., Dec. 4, 2019 /PRNewswire/ -- Hackensack Meridian Health has invested in the clinical-stage biotechnology company Adaptive Phage Therapeutics (APT), as part of the health network\'s successful innovation program, the Bear\'s Den. APT is taking aim at the toughest multi-drug...

 

For more information, please visit
https://www.prnewswire.com:443/news-rele[...]ovation-program-300968546.html

You need to login to post comments.

Feed last updated 2025/04/30 @8:04 AM

0 COMMENTS:

Follow us on Follow Us on Facebook Follow Us on Twitter
©2006 Translations News